CAS 210538-44-6

N-[2-(4-amino-6,7-dimethoxy-5-pyridin-2-ylquinazolin-2-yl)-1,2,3,4-tetrahydroisoquinolin-5-yl]methanesulfonamide

Description:

N-[2-(4-amino-6,7-dimethoxy-5-pyridin-2-ylquinazolin-2-yl)-1,2,3,4-tetrahydroisoquinolin-5-yl]methanesulfonamide, with CAS number 210538-44-6, is a complex organic compound characterized by its unique structural features, which include a methanesulfonamide group and a tetrahydroisoquinoline moiety. This compound exhibits potential biological activity, often investigated for its role in medicinal chemistry, particularly in the development of pharmaceuticals targeting various diseases. The presence of multiple functional groups, such as amino and methoxy groups, contributes to its solubility and reactivity, making it a candidate for further research in drug design. Its molecular structure suggests potential interactions with biological targets, which may lead to therapeutic applications. Additionally, the compound's stability, solubility, and pharmacokinetic properties are essential factors that influence its efficacy and safety profile in biological systems. Overall, this substance represents a significant interest in the field of drug discovery and development.

Formula: C₂₅H₂₆N₆O₄S

InChI: InChI=1/C25H26N6O4S/c1-34-20-13-19-22(21(23(20)35-2)18-8-4-5-11-27-18)24(26)29-25(28-19)31-12-10-16-15(14-31)7-6-9-17(16)30-36(3,32)33/h4-9,11,13,30H,10,12,14H2,1-3H3,(H2,26,28,29)

Synonyms:

• N-(2-(4-amino-6,7-dimethoxy-5-pyridin-2-yl-quinazolin-2-yl)-1,2,3,4-tetrahydro-isoquinolin-5-yl)-methanesulfonamide
• methanesulfonamide, N-[2-[4-amino-6,7-dimethoxy-5-(2-pyridinyl)-2-quinazolinyl]-1,2,3,4-tetrahydro-5-isoquinolinyl]-
• N-{2-[4-amino-6,7-dimethoxy-5-(pyridin-2-yl)quinazolin-2-yl]-1,2,3,4-tetrahydroisoquinolin-5-yl}methanesulfonamide

Taprizosin

CAS: 210538-44-6

Taprizosin

Purity: ≥95%

Molecular weight: 506.58g/mol

Ref: 54-BUP07704

Taprizosin

CAS: 210538-44-6

Taprizosin（UK-338003） is a selective and orally active α1-adrenoceptor antagonist for vasodilatation in the treatment of benign prostatic hyperplasia.

Formula: C₂₅H₂₆N₆O₄S

Purity: 96.34% - 99.11%

Color and Shape: Solid

Molecular weight: 506.58

Ref: TM-T28922